| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00429-014-0946-Y |
| P8608 | Fatcat ID | release_p3jgnzam6baipjpqd5pmjlsp6e |
| P698 | PubMed publication ID | 25431268 |
| P5875 | ResearchGate publication ID | 268876887 |
| P50 | author | Thomas Kilduff | Q16730839 |
| Thomas C Neylan | Q96306595 | ||
| Deepti R Warrier | Q125318896 | ||
| P2093 | author name string | Michael D Schwartz | |
| Alexander T Nguyen | |||
| Jacqueline Vazquez-DeRose | |||
| Thomas K Mathew | |||
| Srishti Gulati | |||
| P2860 | cites work | Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior | Q24315738 |
| The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity | Q24317782 | ||
| Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone | Q27300998 | ||
| The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene | Q28142783 | ||
| The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomnia | Q28272266 | ||
| The energy hypothesis of sleep revisited | Q28383752 | ||
| Sleep-wake sensitive mechanisms of adenosine release in the basal forebrain of rodents: an in vitro study | Q28484972 | ||
| Stimulation of cortical acetylcholine release by orexin A | Q28567181 | ||
| Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation | Q29615680 | ||
| Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. | Q30311232 | ||
| Discharge profiles of identified GABAergic in comparison to cholinergic and putative glutamatergic basal forebrain neurons across the sleep-wake cycle | Q30492253 | ||
| Immunohistochemical evidence for synaptic release of glutamate from orexin terminals in the locus coeruleus | Q30984327 | ||
| Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep--wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. | Q33220272 | ||
| Dynamic changes in GABAA receptors on basal forebrain cholinergic neurons following sleep deprivation and recovery | Q33275036 | ||
| Coreleased orexin and glutamate evoke nonredundant spike outputs and computations in histamine neurons | Q33619265 | ||
| Adenosine in sleep and wakefulness | Q33645408 | ||
| Reduced number of hypocretin neurons in human narcolepsy | Q33923479 | ||
| Discharge patterns of neurons in cholinergic regions of the basal forebrain during waking and sleep | Q34041833 | ||
| Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. | Q34041843 | ||
| Reassessment of the structural basis of the ascending arousal system. | Q34161566 | ||
| Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake | Q34287174 | ||
| Adenosine and sleep-wake regulation | Q34550187 | ||
| The time course of adenosine, nitric oxide (NO) and inducible NO synthase changes in the brain with sleep loss and their role in the non-rapid eye movement sleep homeostatic cascade | Q34588449 | ||
| Promotion of sleep by targeting the orexin system in rats, dogs and humans | Q34607196 | ||
| Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist | Q34628298 | ||
| The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold | Q34975026 | ||
| Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior | Q35052007 | ||
| Sleep-wake mechanisms and basal forebrain circuitry | Q35212793 | ||
| Adenosine inhibits glutamatergic input to basal forebrain cholinergic neurons | Q35994886 | ||
| GABA-to-ACh ratio in basal forebrain and cerebral cortex varies significantly during sleep | Q36238080 | ||
| Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness | Q36690694 | ||
| Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal | Q36729270 | ||
| The role of cholinergic basal forebrain neurons in adenosine-mediated homeostatic control of sleep: lessons from 192 IgG-saporin lesions | Q36917393 | ||
| Adenosine inhibits the excitatory synaptic inputs to Basal forebrain cholinergic, GABAergic, and parvalbumin neurons in mice | Q36941942 | ||
| Microdialysis of GABA and glutamate: analysis, interpretation and comparison with microsensors. | Q36972743 | ||
| Rapid changes in glutamate levels in the posterior hypothalamus across sleep-wake states in freely behaving rats | Q37200112 | ||
| The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats | Q37535058 | ||
| Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats | Q37566598 | ||
| Activation of the basal forebrain by the orexin/hypocretin neurones. | Q37590372 | ||
| Role of zolpidem in the management of insomnia | Q37765629 | ||
| Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal | Q37874775 | ||
| Astrocyte-neuron communication: functional consequences | Q38016361 | ||
| Enhancement of acetylcholine release during REM sleep in the caudomedial medulla as measured by in vivo microdialysis | Q41108760 | ||
| Brain microdialysis of GABA and glutamate: what does it signify? | Q41610607 | ||
| Adenosinergic modulation of rat basal forebrain neurons during sleep and waking: neuronal recording with microdialysis | Q41709009 | ||
| Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss | Q41776277 | ||
| Effects of hypocretin (orexin) neuronal loss on sleep and extracellular adenosine levels in the rat basal forebrain | Q41947724 | ||
| Specific contributions of the basal forebrain corticopetal cholinergic system to electroencephalographic activity and sleep/waking behaviour | Q42434891 | ||
| Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase | Q42458998 | ||
| Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor | Q42464077 | ||
| Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures | Q42470987 | ||
| Adenosine inhibits basal forebrain cholinergic and noncholinergic neurons in vitro | Q42492222 | ||
| Adenosine and sleep homeostasis in the Basal forebrain. | Q42499140 | ||
| Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action | Q42512060 | ||
| Orexins/hypocretins excite basal forebrain cholinergic neurones | Q42513781 | ||
| Glutamatergic stimulation of the basal forebrain elevates extracellular adenosine and increases the subsequent sleep | Q42514206 | ||
| Effects of ibotenate and 192IgG-saporin lesions of the nucleus basalis magnocellularis/substantia innominata on spontaneous sleep and wake states and on recovery sleep after sleep deprivation in rats | Q42523450 | ||
| Effects of lateral preoptic area application of orexin-A on sleep-wakefulness | Q43830853 | ||
| Muscarinic and GABAA receptors modulate acetylcholine release in feline basal forebrain | Q44287819 | ||
| Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. | Q46052798 | ||
| Involvement of adenosine A2A receptor in sleep promotion | Q47755458 | ||
| Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition | Q48020552 | ||
| Acetylcholine and glutamate release during sleep-wakefulness in the pedunculopontine tegmental nucleus and norepinephrine changes regulated by nitric oxide | Q48129453 | ||
| Orexin-A facilitates emergence from propofol anesthesia in the rat. | Q48146396 | ||
| Effects of hypocretin-1 in 192-IgG-saporin-lesioned rats | Q48386927 | ||
| Differential expression of orexin receptors 1 and 2 in the rat brain | Q48693654 | ||
| GABA release in the locus coeruleus as a function of sleep/wake state | Q48702520 | ||
| Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats | Q48824675 | ||
| Acetylcholine liberation from cerebral cortex during paradoxical (REM) sleep | Q48824810 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 923-940 | |
| P577 | publication date | 2014-11-28 | |
| P1433 | published in | Brain Structure and Function | Q13444883 |
| P1476 | title | Hypocretin/orexin antagonism enhances sleep-related adenosine and GABA neurotransmission in rat basal forebrain | |
| P478 | volume | 221 |
| Q47735977 | Benzodiazepines alter nucleotide and nucleoside hydrolysis in zebrafish (Danio rerio) brain |
| Q49989804 | Bmal1 knockdown suppresses wake and increases immobility without altering orexin A, corticotrophin-releasing hormone, or glutamate decarboxylase. |
| Q37107841 | Effect of two GABA-ergic drugs on the cognitive functions of rapid eye movement in sleep-deprived and recovered rats |
| Q93004738 | Hypocretinergic and cholinergic contributions to sleep-wake disturbances in a mouse model of traumatic brain injury |
| Q39052246 | Hypocretins and Arousal |
| Q38687612 | Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders |
| Q93353809 | Intracerebral Adenosine During Sleep Deprivation: A Meta-Analysis and New Experimental Data |
| Q58697746 | Intracerebral microdialysis of adenosine and adenosine monophosphate - a systematic review and meta-regression analysis of baseline concentrations |
| Q39299450 | Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep |
| Q30362407 | The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems. |
| Q34502802 | The Neurobiology of Sleep and Wakefulness |
| Q58786316 | The effect of intracerebroventricular administration of orexin receptor type 2 antagonist on pentylenetetrazol-induced kindled seizures and anxiety in rats |
Search more.